Literature DB >> 21454378

Role of fibulin-5 in metastatic organ colonization.

Henrik Devitt Møller1, Ulrik Ralfkjær, Natascha Cremers, Mika Frankel, Rune Troelsgaard Pedersen, Jörg Klingelhöfer, Hiromi Yanagisawa, Mariam Grigorian, Per Guldberg, Jonathan Sleeman, Eugene Lukanidin, Noona Ambartsumian.   

Abstract

The tumor microenvironment is now recognized as a major factor in determining the survival and growth of disseminated tumor cells at potential metastatic sites. Tumor cells send signals to stroma cells and stimulate them to produce factors that in turn create favorable conditions for tumor cell metastasis. Activated fibroblasts constitute an important component of the tumor-associated stroma. We have previously shown that S100A4 protein produced by stromal fibroblasts in the primary tumor stimulates metastasis formation. Here we show that activated fibroblasts also stimulate the formation of metastases independently of S100A4 expression during organ colonization. To identify genes that could potentially interfere with fibroblast-driven metastasis, we used gene expression profiling of S100A4-deficient fibroblasts treated with and without tumor cell-conditioned media. Five differentially expressed genes encoding cell surface and secreted proteins with potential metastasis-modulating activity were selected. Expression of lymphocyte antigen 6 complex (Ly6c) and matrix metalloproteinase 3 (Mmp3) was upregulated in fibroblasts in response to tumor-conditioned medium, whereas expression of cadherin-16 (Cdh16), Ccn2, and fibulin-5 (Fbln5) was downregulated. Further analysis showed that Fibulin-5 is able to suppress the metastatic colonization of lungs and liver. Additional studies suggest a mechanism in which Fibulin-5 suppresses metastasis formation by inhibiting production of matrix metalloproteinase 9 (MMP9) and reducing the invasive behavior of fibroblasts. Together our data are consistent with the notion that tumors secrete factors that downregulate expression of Fbln5 in fibroblasts at sites of metastatic colonization, in turn upregulating Mmp9 expression and stimulating metastatic organ colonization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454378     DOI: 10.1158/1541-7786.MCR-11-0093

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  12 in total

Review 1.  Avoiding hepatic metastasis naturally: Lessons from the cotton top tamarin (Saguinus oedipus).

Authors:  Martin Tobi; Peter Thomas; Daniel Ezekwudo
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Overexpression of Fibulin-5 Attenuates Ischemia/Reperfusion Injury After Middle Cerebral Artery Occlusion in Rats.

Authors:  Jia Guo; Chuang Cheng; Cindy Si Chen; Xiangfeng Xing; Guanghui Xu; Jinzhou Feng; Xinyue Qin
Journal:  Mol Neurobiol       Date:  2015-05-30       Impact factor: 5.590

Review 3.  Tumor microenvironment: a main actor in the metastasis process.

Authors:  Daniela Spano; Massimo Zollo
Journal:  Clin Exp Metastasis       Date:  2012-02-10       Impact factor: 5.150

4.  Fibulin-5 localisation in human endometrial cancer shifts from epithelial to stromal with increasing tumour grade, and silencing promotes endometrial epithelial cancer cell proliferation.

Authors:  Amy Louise Winship; Kate Rainczuk; Amanda Ton; Eva Dimitriadis
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

Review 5.  EMT transcription factors: implication in osteosarcoma.

Authors:  Guoqiong Yang; Jian Yuan; Kanghua Li
Journal:  Med Oncol       Date:  2013-08-24       Impact factor: 3.064

6.  miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.

Authors:  Tsai-Der Chuang; Harekrushna Panda; Xiaoping Luo; Nasser Chegini
Journal:  Endocr Relat Cancer       Date:  2012-07-22       Impact factor: 5.678

Review 7.  The metastatic niche and stromal progression.

Authors:  Jonathan P Sleeman
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

8.  Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.

Authors:  Xiaojun Chen; Xiaomeng Song; Wen Yue; Dongshi Chen; Jian Yu; Zhi Yao; Lin Zhang
Journal:  Oncotarget       Date:  2015-06-20

9.  Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.

Authors:  Chung-Feng Hwang; Li-Yen Shiu; Li-Jen Su; Wei-Sheng Wang; Shun-Chen Huang; Tai-Jan Chiu; Chao-Cheng Huang; Yen-Yi Zhen; Hsin-Ting Tsai; Fu-Min Fang; Tai-Lin Huang; Chang-Han Chen
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

Review 10.  Tumour progression and metastasis.

Authors:  Francisco Arvelo; Felipe Sojo; Carlos Cotte
Journal:  Ecancermedicalscience       Date:  2016-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.